Share Email Print

Proceedings Paper

Breast cancer in tough economic times: disruptive technology emerging
Author(s): Phillip Bretz; Richard Lynch
Format Member Price Non-Member Price
PDF $14.40 $18.00
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

The objective of this study was to investigate the efficacy of melding three emerging technologies: Pharmacogenomics, Modified Military Digital Infrared and Halo to establish their capability in diagnosing ultra-small breast cancers as well as other cancers. Mammography, ultrasound and MRI technologies have been available for over forty years, however, there is still no uniform utilization by women, costs continue to escalate and problems persist like high false positive rates for MRI and high false negative rates for mammography. Of the first 500 IR patients, 499 were female and 1 male. Of 550 OncoVue patients, 129 opted to undergo IR. A total of 19 were lost to follow-up. Patients who were negative on IR: 419/500 (84%). Of these, 63/419 went to biopsy because of findings of other diagnostic modalities. Of these 61/63 with negative IR had a negative biopsy. Of two missed, one was the fault of the investigator but was included. In this series 2/500 were false negative (0.4%). The sensitivity was 96% and the specificity was 79%. In total, 46 cancers were identified including five outside the breast (e.g. 2 lung cancers). A total of 92 MRIs were done and in 71/92 patients IR and MRI agreed. Using these three modalities the smallest cancer found was a 4 mm invasive cancer. The study demonstrated that these diagnostic techniques can dramatically lower cost and provide results at least as good as the older paradigms. Further research and a multicenter clinical trial are necessary to shift the paradigm of breast cancer diagnosis and treatment.

Paper Details

Date Published: 18 May 2012
PDF: 21 pages
Proc. SPIE 8354, Thermosense: Thermal Infrared Applications XXXIV, 83540V (18 May 2012); doi: 10.1117/12.921368
Show Author Affiliations
Phillip Bretz, Desert Breast and Osteoporosis Institute (United States)
Richard Lynch, Infrared Institute of the Desert (United States)

Published in SPIE Proceedings Vol. 8354:
Thermosense: Thermal Infrared Applications XXXIV
Douglas Burleigh; Gregory R. Stockton, Editor(s)

© SPIE. Terms of Use
Back to Top